{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:21:20Z","timestamp":1772601680804,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>The liver plays a key role in the metabolism of proteins. Liver dysfunction affects many organs because it communicates with the spleen and all digestive organs through the portal vein. Additionally, the kidney is an organ that is closely related to the liver and is involved in liver diseases. Glomerulonephritis is an important extrahepatic manifestation of chronic hepatitis B virus (HBV) infection. Nucleos(t)ide analog (NA) therapy effectively suppresses HBV replication by inhibiting HBV polymerase, thus decreasing the levels of serum HBV-DNA and delaying the progression of cirrhosis. Although NA therapy is recommended for all patients with chronic HBV infection, regardless of the level of renal dysfunction, there is limited information on NA use in patients with chronic kidney disease. In addition, in patients with end-stage liver cirrhosis, hepatorenal syndrome can be fatal. Hence, we should take into account the stage of impaired renal function in patients with cirrhosis. The aims of this article are to review the epidemiology, clinical presentation, treatment, and prevention of HBV-associated nephropathy.<\/jats:p>","DOI":"10.3390\/diseases6020052","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:20:36Z","timestamp":1529407236000},"page":"52","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Renal Impairment in Chronic Hepatitis B: A Review"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9135-3092","authenticated-orcid":false,"given":"Hiroteru","family":"Kamimura","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Setsu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-1219","authenticated-orcid":false,"given":"Naruhiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yokoo","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamagiwa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(71)92572-4","article-title":"Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane","volume":"2","author":"Combes","year":"1971","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.282.24.2305","article-title":"Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: A randomized controlled trial","volume":"282","author":"Kahn","year":"1999","journal-title":"JAMA"},{"key":"ref_3","first-page":"512","article-title":"Fanconi syndrome and chronic renal failure in a chronic hepatitis B monoinfected patient treated with tenofovir","volume":"107","author":"Matos","year":"2015","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11901-010-0042-6","article-title":"Hepatitis B and renal disease","volume":"9","author":"Chan","year":"2010","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int."},{"key":"ref_7","first-page":"34","article-title":"Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy","volume":"40","author":"Takekoshi","year":"1991","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0016-5085(95)90343-7","article-title":"Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa","volume":"109","author":"Conjeevaram","year":"1995","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004670050417","article-title":"In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis","volume":"12","author":"He","year":"1998","journal-title":"Pediatr. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ki.2014.363","article-title":"A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan","volume":"87","author":"Chen","year":"2015","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000348478","article-title":"Re-evaluation of the classification system for membranoproliferative glomerulonephritis","volume":"181","author":"Lu","year":"2013","journal-title":"Contrib. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000168844","article-title":"Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy","volume":"15","author":"Mouthon","year":"1995","journal-title":"Am. J. Nephrol."},{"key":"ref_13","first-page":"323","article-title":"The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis","volume":"63","author":"Lai","year":"1987","journal-title":"Q. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000185802","article-title":"The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia","volume":"54","author":"Lai","year":"1990","journal-title":"Nephron"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0033-1345722","article-title":"Immunosuppression and HBV reactivation","volume":"33","author":"Shouval","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_16","first-page":"142","article-title":"Treatment of hepatitis B virus-associated nephropathy in black children","volume":"40","author":"Bhimma","year":"1993","journal-title":"Clin. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0016-5085(78)90092-6","article-title":"Reversibility of hepatitis B virus-induced glomerulonephritis and chronic active hepatitis after spontaneous clearance of serum hepatitis B surface antigen","volume":"75","author":"Knecht","year":"1978","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"c41","DOI":"10.1159\/000324652","article-title":"Treatment of hepatitis B virus-associated nephropathy","volume":"119","author":"Elewa","year":"2011","journal-title":"Nephron Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2893.2003.00450.x","article-title":"Peginterferon alpha-2a (40 kDa): An advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"10","author":"Cooksley","year":"2003","journal-title":"J. Viral Hepat."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Yang, Y., Ma, Y., Chen, D., Zhuo, L., and Li, W. (2016). A Meta-analysis of antiviral therapy for hepatitis B virus-associated membranous nephropathy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160437"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Salvaggio, S.E., Giacomelli, A., Falvella, F.S., Oreni, M.L., Meraviglia, P., Atzori, C., Clementi, E.G.I., Galli, M., and Rusconi, S. (2017). Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2497-3"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleic Acids"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1310\/hct1404-149","article-title":"Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infection","volume":"14","author":"Cortez","year":"2013","journal-title":"HIV Clin. Trials"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S757","DOI":"10.1093\/infdis\/jix461","article-title":"Viral factors affecting the clinical outcomes of chronic hepatitis B","volume":"216","author":"Yang","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: Two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Parikh","year":"2008","journal-title":"Hepatology"},{"key":"ref_28","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin. Liver Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study","volume":"134","author":"Guevara","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"Dolomanova","year":"2014","journal-title":"Hepatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10620-017-4897-z","article-title":"Cystatin C is a gender-neutral glomerular filtration rate biomarker in patients with cirrhosis","volume":"63","author":"Mindikoglu","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/hep4.1109","article-title":"Neutrophil gelatinase-associated lipocalin level is a prognostic factor for survival in rat and human chronic liver diseases","volume":"1","author":"Yoshikawa","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ndt\/17.6.1005","article-title":"Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease","volume":"17","author":"Gehrmann","year":"2002","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/j.ajkd.2008.07.021","article-title":"Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and\/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: A post hoc analysis of a randomized controlled trial","volume":"53","author":"Waanders","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ki.2013.363","article-title":"Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury","volume":"85","author":"Aregger","year":"2014","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11010-005-9047-9","article-title":"Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease","volume":"284","author":"Kamijo","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","article-title":"Urinary interleukin-18 is a marker of human acute tubular necrosis","volume":"43","author":"Parikh","year":"2004","journal-title":"Am. J. Kidney Dis."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/6\/2\/52\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:09:14Z","timestamp":1760195354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/6\/2\/52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["diseases6020052"],"URL":"https:\/\/doi.org\/10.3390\/diseases6020052","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}